IGIdrian García García

Idrian García García

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Idrian García García has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and psychosexual characterization of patients with female orgasmic disorder

    by Mey-King Mey-King Romero Hung, Rodolfo Javier Aguilar Amaya, Aimet Dayamí Rodríguez Martínez, Miozotis Serrano Ramírez, Yanelys Soto Plutín, Lisbel Garzón Cutiño, Idrian García García

    Introduction: female orgasmic disorder (FOD) is a health problem that affects the physical and mental well-being of women, as well as their family, social and work balance. It has a high prevalence and incidence, and has organic and non-organic causes. Aim: to characterize patients with FOD assessed in a specialized consultation over a 15-month period. Methods: a descriptive, observational, cross-sectional study was conducted. Theoretical, empirical and statistical-mathematical methods were used. In the sexual counseling and therapy consultation for sexual ailments at the National Center for Sexology (CENESEX) in Cuba, 39 patients diagnosed with FOD, ranging from 16 to 45 years, were characterized. Their clinical histories were reviewed and a questionnaire written by CENESEX specialists was used as a data collection procedure. Results: in the evaluated patients with TOF, deficiencies related to sexual illiteracy were identified, particularly in relation to the organs of sexual response and the human sexual response cycle, attachment to mysticism and false beliefs, lack of knowledge of risk factors associated with TOF and inappropriate lifestyles.

  • Open Access

    Analysis of scientific publications by professors of a Faculty of Medical Sciences

    by Idrian García García, Sergio González García, Hamna Coello Caballero, Lisbel Garzón Cutiño, Lourdes Hernández Cuétara

    Introduction: scientific publications are considered the final step of a research and are an excellent tool to characterize the scientific output of a university. Objective: to characterize the scientific production of the faculty of the Faculty of Medical Sciences "Miguel Enriquez", based on their scientific publications, in the period 2016-2022. Methods: a descriptive, cross-sectional, retrospective, observational, descriptive study was carried out. The universe was constituted by the publications of the faculty professors, grouped by teaching departments. Articles, complete books and chapters, and monographs were included. The publications were analyzed according to the time of dedication of the professor to the teaching activity, and annual indexes of scientific productivity were calculated.Results: a total of 845 scientific publications were counted in a faculty composed of 444 professors from 17 teaching departments. In a quarter of them, the main author was from the Diagnostic Means department. The number of authorships per professor was 1487 during the period, with the Clinical Sciences Department standing out. Most of the works were published in journals indexed in prestigious international databases (Groups I-II), with a predominance of publications by full-time professors. The highest indicators of annual productivity, both per department and per professor, were obtained by the Diagnostic Means and Graduate and Research departments. Professors with a scientific degree and full professors and researchers were the most productive. Conclusions: The analysis of seven years of scientific publications of the faculty of the "Miguel Enriquez" Faculty shows that there is a diminished scientific production, which mainly corresponds to the professors of higher rank or category


  • Open Access

    Academic results during the epidemic period at the Faculty of Medical Sciences Miguel Enríquez

    by Daisy Bencomo García, Lissette Cárdenas de Baños, Niurka Hernández Labrada, Jhossmar Cristians Auza Santivañez, Idrian García García, Sergio González García

    Introduction: the years 2020 and 2021 were characterized by the COVID-19 epidemic in Cuba, which caused the adaptation of academic courses, with the premise of making the training process more flexible, based on the suspension of face-to-face activities and the modification of the teaching curriculum. Objective: to describe the state exam results during the epidemic period. Methods: an observational, descriptive, retrospective study was carried out based on analyzing the promotion reports and the official models 36.19 and 36.20 of the Postgraduate Department, corresponding to 2020-2021. Results: 173 residents took the state examination, 111 from medical specialties and 62 from stomatological specialties, with promotion of 100 %. 49,7 % obtained final grades above 95 points and 78,0 % above 90 points in the state exam. The residents of the Dermatology and Intensive and Emergency Medicine specialties received the best teaching results. Conclusions: the Faculty of Medical Sciences "Miguel Enríquez", during the epidemic period, graduated, with quality, all the residents who took the state exam


  • Open Access

    Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study

    by for the NeuroEPO Study Group, Orestes Santos-Morales, Alina Díaz-Machado, Daise Jiménez-Rodríguez, Yaisel Pomares-Iturralde, Tatiana Festary-Casanovas, Carlos A. González-Delgado, Sonia Pérez-Rodríguez, Eulalia Alfonso-Muñoz, Carmen Viada-González, et al.

    Delivery of therapeutic agents as erythropoietin (EPO) into Central Nervous System through intranasal route could benefit patients with neurological disorders. A new nasal formulation containing a non-hematopoietic recombinant EPO (NeuroEPO) has shown neuroprotective actions in preclinical models. In the current study, the safety of NeuroEPO was evaluated for the first time in humans. A phase I, randomized, parallel, open-label study was carried out in healthy volunteers. They received, intranasally, 1 mg of NeuroEPO every 8 h during 4 days (Group A) or 0.5 mg of NeuroEPO (Group B) with the same schedule. The working hypothesis was that intranasal NeuroEPO produce <10% of severe adverse reactions in the evaluated groups. Therefore, a rigorous assessment of possible adverse events was carried out, which included tolerance of the nasal mucosa and the effect on hematopoietic activity. Clinical safety evaluation was daily during treatment and laboratory tests were done before and on days 5 and 14 after starting treatment. Twenty-five volunteers, 56% women, with a mean age of 27 yrs. were included. Twelve of them received the highest NeuroEPO dose. Twenty types of adverse events occurred, with headache (20%) and increase of hepatic enzymes (20%) as the most reported ones. Nasopharyngeal itching was the most common local event but only observed in four patients (16%), all of them from the lowest dose group. About half of the events were very probably or probably caused by the studied product. Most of the events were mild (95.5%), did not require treatment (88.6%) and were completely resolved (81.8%). No severe adverse events were reported. During the study the hematopoietic variables were kept within reference values. NeuroEPO was a safe product, well tolerated at the nasal mucosa level and did not stimulate erythropoiesis in healthy volunteers. Cuban Public Registry of Clinical Trials RPCEC00000157 , June 10, 2013.


  • Open Access

    Efficacy of Plectranthus amboinicus (Lour.) Spreng (French oregano) tablets in patients with common cold: a randomized, double-blind, placebo-controlled study

    by Yolanda A Rodríguez-Cámbara, Daise Jiménez-Rodríguez, Jorge E Rodríguez-Chanfrau, Idrian García-García


  • Open Access

    Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study

    by Magnelis Machado-Leiva, Calprost Study Group, Daise Jiménez-Rodríguez, Tatiana Festary-Casanovas, Deydree C. Silveira-Pacheco, Emilio S. Barroso-De la Cruz, Mariela Suárez-Reyes, Genma Salas-Cruz, Haydee Wong-Arocha, Roberto Fernández-Viera, et al.

    Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study